摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-叔丁基-4-硝基苯磺酰胺 | 49690-09-7

中文名称
N-叔丁基-4-硝基苯磺酰胺
中文别名
——
英文名称
N-dimethylethyl-4-nitrobenzenesulfonamide
英文别名
N-(tert-butyl)-4-nitrobenzenesulfonamide;N-tert-butyl-4-nitrobenzenesulfonamide;4-nitro-benzenesulfonic acid tert-butylamide;4-Nitro-benzolsulfonsaeure-tert-butylamid;N-tert-Butyl 4-Nitrophenylsulfonamide
N-叔丁基-4-硝基苯磺酰胺化学式
CAS
49690-09-7
化学式
C10H14N2O4S
mdl
MFCD00443679
分子量
258.298
InChiKey
YVSUQTZCHSBFEN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    100
  • 氢给体数:
    1
  • 氢受体数:
    5

安全信息

  • 海关编码:
    2935009090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    室温且干燥

SDS

SDS:9e64f7d21137dda60fb61acdb4e52d41
查看
Material Safety Data Sheet

Section 1. Identification of the substance
N-tert-Butyl 4-nitrophenylsulfonamide
Product Name:
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P302+P352: IF ON SKIN: Wash with soap and water
P321: Specific treatment (see on this label)
P405: Store locked up

Section 3. Composition/information on ingredients.
N-tert-Butyl 4-nitrophenylsulfonamide
Ingredient name:
CAS number: 49690-09-7

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C10H14N2O4S
Molecular weight: 258.3

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, sulfur oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-叔丁基-4-硝基苯磺酰胺三氯化硼 作用下, 以 二氯甲烷 为溶剂, 反应 0.5h, 以78%的产率得到4-硝基苯磺酰胺
    参考文献:
    名称:
    三氯化硼是一种用于叔丁基芳基磺酰胺脱保护的有效选择剂
    摘要:
    已经开发了一种快速,温和且选择性的方法,该方法利用BCl 3作为脱保护剂对叔丁基芳基磺酰胺进行脱保护。在这些条件下使用的各种叔丁基芳基磺酰胺以高收率得到相应的伯磺酰胺。该方法不裂解甲氧基,并防止叔丁基结合到富电子芳环上。
    DOI:
    10.1016/s0040-4039(03)01020-7
  • 作为产物:
    描述:
    对硝基苯磺酰氯 以97的产率得到N-叔丁基-4-硝基苯磺酰胺
    参考文献:
    名称:
    Process for the preparation of 4-(imidazol-1-yl)benzenesulfonamide derivatives
    摘要:
    制备式I中R1代表可选取代的芳基或杂环基的4-(咪唑-1-基)苯磺酰胺衍生物的方法包括用酸处理式II的化合物,其中R1具有在式I中定义的相同含义,But代表叔丁基。式I中的4-(咪唑-1-基)苯磺酰胺衍生物可用作抗炎药物。
    公开号:
    US08476456B2
点击查看最新优质反应信息

文献信息

  • SNAAP Sulfonimidate Alkylating Agent for Acids, Alcohols, and Phenols
    作者:Tom Maricich、Matthew Allan、Brett Kislin、Andrea Chen、Fan-Chun Meng、Christine Bradford、Nai-Chia Kuan、Jeremy Wood、Omonigho Aisagbonhi、Alethea Poste、Dustin Wride、Sylvia Kim、Therese Santos、Michael Fimbres、Dianne Choi、Haydi Elia、Joseph Kaladjian、Ali Abou-Zahr、Arturo Mejia
    DOI:10.1055/s-0033-1339921
    日期:——
    iodoethane and silver(I) oxide in dichloromethane. This sulfonimidate directly ethylates various acids to esters; the stronger the acid, the faster it alkylates and in higher yield. It readily ethylates alcohols and phenols to ethers at room temperature in the presence of tetrafluoroboric acid catalyst without molecular rearrangements or racemization. We have defined these reactions as SNAAP alkylations:
    摘要 稳定,晶状ñ -叔丁基-4- nitrobenzenesulfonimidate已经通过直接O形乙基高收率制备ñ -叔丁基-4-硝基苯磺酰胺与碘乙烷二氯甲烷(I)氧化物。该亚磺酸磺酸盐将各种酸直接乙基化为酯。酸越强,烷基化速度越快,收率越高。在四硼酸催化剂存在下,在室温下容易将醇和乙基化为醚,而不会发生分子重排或外消旋化。我们定义这些反应如烷基化SNAAP:小号ubstitution,Ñ的ucleophilic一个的CID,一个lcohols和p henols]。所述硬sulfonimidate烷化剂是化学选择性的,宁愿氧气>氮气>。烷基化的磺酰胺副产物易于再循环至磺酰亚胺酯。 稳定,晶状ñ -叔丁基-4- nitrobenzenesulfonimidate已经通过直接O形乙基高收率制备ñ -叔丁基-4-硝基苯磺酰胺与碘乙烷二氯甲烷(I)氧化物。该亚磺酸磺酸盐将各种酸直
  • [EN] POTENT DUAL BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS<br/>[FR] PUISSANTS DOUBLES INHIBITEURS DE BRD4 ET DE KINASE À UTILISER EN TANT QU'AGENTS THÉRAPEUTIQUES ANTICANCÉREUX
    申请人:H LEE MOFFITT CANCER CT & RES
    公开号:WO2016022460A1
    公开(公告)日:2016-02-11
    Disclosed herein are compounds that are inhibitors of BRD4 and their use in the treatment of cancer. Methods of screening for selective inhibitors of BRD4 are also disclosed. In certain aspects, disclosed are compounds of Formula I-IV.
    本文披露了一些抑制BRD4的化合物及其在癌症治疗中的应用。还披露了筛选BRD4选择性抑制剂的方法。在某些方面,披露了Formula I-IV的化合物。
  • Hepatitis C Virus Inhibitors
    申请人:Sin Ny
    公开号:US20080119461A1
    公开(公告)日:2008-05-22
    Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    抑制丙型肝炎病毒的抑制剂具有一般公式。包含这些化合物的组合物以及使用这些化合物抑制HCV的方法也被披露。
  • [EN] BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS<br/>[FR] INHIBITEURS DE BRD4-KINASE À UTILISER EN TANT QU'AGENTS THÉRAPEUTIQUES ANTICANCÉREUX
    申请人:H LEE MOFFITT CANCER CENTER & RES INST INC
    公开号:WO2017066428A1
    公开(公告)日:2017-04-20
    Disclosed herein are compounds that are inhibitors of BDR4 and their use in the treatment of cancer. Methods of screening for selective inhibitors of BDR4 are also disclosed. In certain aspects, disclosed are compounds of Formula I through IV.
    本文披露了一些抑制BDR4的化合物及其在癌症治疗中的应用。还披露了筛选BDR4选择性抑制剂的方法。在某些方面,披露了公式I至IV的化合物。
  • Visible-light-mediated, nitrogen-centered radical amination of tertiary alkyl halides under metal-free conditions to form α-tertiary amines
    作者:Alexander C. Brueckner、Erin N. Hancock、Evan J. Anders、Matthew M. Tierney、Heather R. Morgan、Kristina A. Scott、Angus A. Lamar
    DOI:10.1039/c6ob00616g
    日期:——
    A mild and operationally convenient amino-functionalization of a range of tertiary alkyl halides by reaction with iminoiodinanes (PhINNs) and I2 has been developed. According to the mechanistic experiments described within, the reaction is speculated to proceed through a light-promoted, N-centered radical pathway involving a N,N-diiodosulfonamide reactive species. This method of direct N-incorporation
    已经开发了通过与亚丁烷(PhI NNs)和I 2反应的一系列叔烷基卤化物的温和且方便操作的基官能化。根据其中描述的机理实验,推测反应是通过光促进的,以N为中心的自由基途径进行的,该途径涉及N,N-二磺酰胺反应性物质。这种直接掺入N的方法为生产α-叔胺提供了一种有吸引力的替代方法,α-叔胺是在各种生物活性分子中发现的具有合成挑战性的结构类别。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫